Nextcure Inc (NXTC)

Shares of Nextcure Inc (NXTC) dropped by 19.31% from $1.45 to $1.17 in the trading on Thursday, December 14, 2023. The reason why NXTC down today is due to the company on its clinical pipeline. Nextcure Inc disclosed that it was currently conducting an ongoing Phase 1b trial of NC410 in combination with pembrolizumab. Additionally, the company stated that it was actively seeking strategic partners to accelerate the development of its pipeline. It's possible that investors reacted negatively to this update, which may have contributed to the sharp decrease in NXTC's share price on December 14, 2023.